ALARIS Medical to Consolidate Instromedix Acquisition in San Diego; Expects Cost Savings and Growth Synergies.

SAN DIEGO--(BUSINESS WIRE)--Feb. 22, 1999--ALARIS Medical Inc. (Nasdaq:ALRS) Monday announced that it plans to consolidate the operations of its Portland-based Instromedix Division into its San Diego facilities.

The company expects to achieve cost savings and consolidation synergies as a result of these changes. In connection with relocation and integration activities, the company expects to incur non-recurring charges of approximately $5 million before related income tax benefits, primarily in the first half of 1999.

The relocation is expected to add about 75 jobs in the San Diego area and to reduce jobs in the Portland area by nearly 100. The company said its first priority is to ensure a smooth transition for employees affected by this change and to minimize any disruption to its customers.

ALARIS Medical's acquisition of Instac event monitoring and pacemaker follow-up systems. These products are used primarily in the rapidly growingusiness with our R&D base in San Diego.

"Additionally, we feel the San Diego business community, with its biomedical and telecommunications technologies and leading- voice-over-data communications technology with drug infusion and patient monitoring technologies. In additiroduct portfolio," Mercer added.

ALARIS Medical Inc., through its operating company, ALARIS Medical Systems Inc., is known for its IMED(R) and IVAC(R) brand names ocompany's products are distributed to more than 120 countries worldwide. In addition to its San Diego world hs for demand and acceptance of new and existing products, technologies and opportunities, regulatory approvals and market and industry segment growth. Actual results could vary materially from these expected results due to a variem 10-K for the year ended Dec. 31, 1997.